Loading...
OTC Markets
Totals
Securities
12,309
Dollar Vol
$674.3M
Share Vol
1B
Trades
72,342

OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.

GILD
Gilead Sciences, Inc.

Common Stock

110.04

0.98

0.90%

Delayed (15 Min) Trade Data: 10:38am 07/16/2025
Gilead Sciences, Inc. Company Logo

333 Lakeside Drive

Foster City, CA 94404

www.gilead.com

650-574-3000

Business Description
Not available
Financial Reporting
Reporting Status
U.S. Reporting: SEC Reporting
Audited Financials
Audited
Latest Report
CIK
0000882095
Fiscal Year End
12/31
Company Officers & Contacts
John C. Martin
President, CEO

John F. Milligan
CFO, COO

Board of Directors

Not available

Other Company Insiders

Not available

Other Company Insiders are all persons or entities beneficially owning 10% or more of any class of the issuer's securities. Together, officers, directors and other company insiders comprise Company Insiders.
Service Providers

Not available

Profile Data
SIC - Industry Classification
2836 - Biological products, except diagnostic
Incorporation Information
DE, US
Employees
Not Available
Shell
No
Products and Services

Not available

Company Facilities

Not available

Nasdaq
Daily Advancers
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.